top of page
Search

Happy New year - and UPDATED COVID-19 treatment guidelines!

With the New Year, new guidelines! Our COVID-19 therapeutic working group has revised our COVID-19 management guidelines. Of note, empiric antibiotics are strongly DISCOURAGED for mild and moderate disease. Investigational or off-label therapies should NOT be given outside of clinical trials (several ongoing clinical trials at the MUHC); Criteria are proposed for potential identification of hyperimmune response, with recommendations to consult ID for severe cases.

ree


 
 
 

Recent Posts

See All
New guide : IV to PO

The ASP committee is happy to make available the new guide IV to PO! It covers situation in which a switch to PO is indicated for certain...

 
 
 
We have a new look!

The MUHC ASP website has gone through a re-do: combination of spring cleaning and cosmetic changes, but keeping all the content! check...

 
 
 
Linezolid TDM

INESSS approved the TDM of Linezolid in May 2024 It is now available in the MUHC (via HSJ labs) The ASP committee is happy to publish a...

 
 
 

Comentários


logo2.png

1001 Decarie Blvd, Montreal, Quebec H4A 3J1, Canada

+1 514-934-1934

bottom of page